Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 20;136(20):2397-2411.
doi: 10.1097/CM9.0000000000002848. Epub 2023 Sep 8.

Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms

Affiliations

Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms

Feng Jiao et al. Chin Med J (Engl). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
Process of diagnosis and management of pNENs. pNENs: Pancreatic neuroendocrine neoplasms; F-pNEN: Functionning pancreatic neuroendocrine neoplasm; NF-pNEN: Non-functioning pancreatic neuroendocrine neoplasm.
Figure 2
Figure 2
Algorithm for the systemic therapy of pNENs. pNENs: Pancreatic neuroendocrine neoplasms; SSA: Somatostatin analogs; PPI: Proton pump inhibitor; SSTR: Somatostatin receptors; 5-FU: 5-Fluorouracil.

Similar articles

References

    1. Dasari A Shen C Halperin D Zhao B Zhou S Xu Y, et al. . Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 2017;3: 1335–1342. doi: 10.1001/jamaoncol.2017.0589. - PMC - PubMed
    1. Fan JH Zhang YQ Shi SS Chen YJ Yuan XH Jiang LM, et al. . A nation-wide retrospective epidemiological study of gastroenteropancreatic neuroendocrine neoplasms in China. Oncotarget 2017;8: 71699–71708. doi: 10.18632/oncotarget.17599. - PMC - PubMed
    1. Wu W Jin G Li H Miao Y Wang C Liang T, et al. . The current surgical treatment of pancreatic neuroendocrine neoplasms in China: A national wide cross-sectional study. J Pancreatol 2019;2: 35–42. doi: 10.1097/JP9.0000000000000019.
    1. Alvarez MJ Subramaniam PS Tang LH Grunn A Aburi M Rieckhof G, et al. . A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors. Nat Genet 2018;50: 979–989. doi: 10.1038/s41588-018-0138-4. - PMC - PubMed
    1. Leoncini E, Carioli G, La Vecchia C, Boccia S, Rindi G. Risk factors for neuroendocrine neoplasms: A systematic review and meta-analysis. Ann Oncol Off J Eur Soc Med Oncol 2016;27: 68–81. doi: 10.1093/annonc/mdv505. - PubMed